Cayman Chemical ANTIBODY GM 6001 500ug
A 5-HT2B receptor antagonist (Ki 0.5 nM) selective for 5-HT2B over 5-HT2A and 5-HT2C receptors (Kis 19.5 and 24.55 nM respectively) reduces L5/L6 spinal nerve ligation-induced hind paw tactile allodynia in a rat model of neuropathic pain at an intrathecal dose of 100 nmol reduces hyperlocomotion induced by cocaine in rats at 0.63 mg/kg